AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Modulus Discovery Closes $20.4M Usd Series C

Mar 03, 2022•over 3 years ago

Round Type

series c

Tokyo

Description

Modulus Discovery, Inc., a preclinical-stage computation-driven drug discovery firm, announces the successful closing of its Series C funding round in the amount of 2.34B JPY (approximately $20.4M USD). Series C investors include Green Coinvest Investment Limited Partnership., SBI Group., Heights Capital Management, Inc., and existing shareholders including UTokyo Innovation Platform Co., Ltd., JAFCO Group Co., Ltd., Keio Innovation Initiative, Inc. (KII), and Fast Track Initiative, Inc. Modulus has raised to date, a total of 5.86B JPY (approximately $51M USD).

Company Information

Company

Modulus Discovery

Location

Tokyo, Tokyo, Japan

About

In addition to accelerating its existing pipeline of over 10 R&D programs, the company aims to significantly increase its business value through expansion of its platform infrastructure, collaborations with industry and academic partners, and increase personnel in R&D and operations to deliver innovative drug candidates through clinical partnerships and additional drug discovery collaborations. The company is pursuing its proprietary portfolio of small-molecule discovery programs and collaborations through integration of its unique core biology insights, cutting-edge discovery platform, and scalable networked operations. We are so thrilled to be part of Modulus’ mission in the discovery of new medicines and treatments for more patients in need.”About Company;Modulus Discovery, Inc., is a preclinical-stage computation-driven drug discovery firm with offices in Tokyo and Boston.

FundzWatch™ Score

Medium Activity